EUVIMED · CrossrefJournal
European Atherosclerosis Journal
ISSN 2785-7115 · S.I.Te.C.S Societa Italiana di Terapia Clinica e Sperimentale
Latest articles
Parental history of cardiovascular events and atherosclerosis among stroke patients and partners – The first and second generation in the Norwegian Stroke in the Young Study
An Observational Longitudinal Multicenter Prospective Study to Evaluate Treatment Patterns in High, Very High, and Extreme Cardiovascular Risk Patients with Hypercholesterolemia, Including Familial Hypercholesterolemia, Over a 1-Year Follow-Up: Protocol of the TRAP-HC Study
Adipo-neuroinflammation, cognitive impairment and surrogate markers of cardiovascular risk in patients with MASLD
Ultrasound evaluation of carotid perivascular adipose tissue thickness as a potential marker of atherosclerosis and cardiovascular risk
Extracellular vesicles isolated from patients with heart failure retain proinflammatory features
Achievement of LDL cholesterol targets in HIV-positive patients
Colonic (poly)phenol metabolites as promising tools to control inflammation and prevent cardiovascular disease
Free fatty acids impair steroidogenesis and promote apoptosis in leydig cells: A new link between metabolic dysfunction and hypogonadism
Effect of elexacaftor/tezacaftor/ivacaftor therapy on serum lipoprotein functions in adults with cystic fibrosis
Age-Related Enhancement of COX-1–Mediated Thromboxane Production in Patients with Atrial Fibrillation
Lipoprotein(a) does not correlate with hypertensive mediated organ damage and subsequent cardiovascular events in a primary prevention cohort
Lipoprotein(a) levels across histological severity in metabolic dysfunction–associated steatotic liver disease
XI Spring Meeting of the Young Researchers of SID, SIGG, SIIA, SIMI, SIPREC, SISA
TechNote - Minimum Preanalytical Information for the Publication of Studies on Circulating Cell-Free microRNA-based Biomarkers
MicroRNAs in the progression of atherosclerosis: rise and fall of the atherosclerotic plaque
Combination therapy in the guidelines: from high-intensity statins to high-intensity lipid-lowering therapies
Welcome to European Atherosclerosis Journal, a new Open Access Journal: European Atherosclerosis Journal, a new Open Access Journal
The pharmacology of cholesterol-lowering drugs: The pharmacology of cholesterol-lowering drugs
Cholesterol-lowering drugs: Focus on Ezetimibe: Cholesterol-lowering drugs: Focus on ezetimibe
Lipid-lowering for the prevention of cardiovascular disease in the new era: A practical approach to combination therapy: Lipid-lowering and combination therapy
FindMyLipidClinic.com: A global Directory of lipid clinics and patient organisations to improve dyslipidemia care: FindMyLipidClinic.com
Metabolic impact of extrahepatic PCSK9 modulation: Extrahepatic PCSK9 modulation
European, Russian and American Clinical Guidelines on dyslipidemias management – where do we stand? European, Russian, and US guidelines on dyslipidemias
Combining family history of coronary heart disease and individual genetic predisposition to predict the risk of major coronary events: Selected Abstract - SITeCS Congress 2022
Effect of the deletion of prenylcysteine-oxidase 1 (PCYOX1) on arterial thrombosis in an animal model: Selected Abstract - SITeCS Congress 2022
Nutraceutical alternatives to red yeast rice extract/monacolin K for moderate hypercholesterolaemia: Current evidence and knowledge gaps: Nutraceuticals and hypercholesterolaemia
Are we seeing the light at the end of the tunnel for high lipoprotein(a)? Lipoprotein(a)
Role of histone deacetylase 3 (HDAC3) in adipose tissue metabolism and immunophenotype: Selected Abstract - SITeCS Congress 2022
Impact of dietary choline on lipid metabolism and atherosclerosis development in apoEKO mice deficient or overexpressing apolipoprotein A-I: Selected Abstract - XVI SITeCS Congress
The XVI National Congress of the Società Italiana di Terapia Clinica e Sperimentale (SITeCS): Conference report
EUVIMED